Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21026228 | 0.86 | DRD3 (0.57) | HTR2ADRD3 | |
| SCHEMBL21026223 | 0.82 | HTR2A (0.82) | HTR2ADRD3 | |
| SCHEMBL21026348 | 0.77 | DRD3 (0.61) | HTR2ADRD3 | |
| SCHEMBL21026469 | 0.77 | DRD3 (0.54) | HTR2ADRD3 | |
| SCHEMBL21026108 | 0.77 | DRD3 (0.61) | HTR2ADRD3 | |
| SCHEMBL4202827 | 0.75 | HTR2A (1.00) | HTR2ADRD3 | |
| SCHEMBL15859550 | 0.75 | HTR2A (1.00) | HTR2ADRD3 | |
| SCHEMBL21729945 | 0.74 | DRD2 (0.69) | HTR2ADRD3 | |
| SCHEMBL604688 | 0.73 | HTR2A (1.00) | HTR2ADRD3 | |
| SCHEMBL15866499 | 0.73 | HTR2A (1.00) | HTR2ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10301277-B2 | Substituted ureas and methods of treating mental illness using the same | ZHEJIANG JINGXIN PHARMACEUTICAL CO., LTD. (CN) | 2019-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301277-B2 | Substituted ureas and methods of treating mental illness using the same | CRHR1, UTS2R, HTR2C | HTR2A 23/4885DRD3 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.